TEST BANK FOR Advanced Practice Nursing
c c c c c
c in the Care of Older Adults, 3rd Edition
c c c c c c c c
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
c c c c c c c c
, Answers at the end of the Chapter
c c c c c c c
Chapter 1: Changes with Aging
c c c c
Multiple cChoice
Identify cthe c choice cthat cbest ccompletes cthe cstatement cor canswers cthe cquestion.
1. The cmajor cimpact cofcthe cphysiological cchanges cthat coccur cwith caging cis:
A. Reduced cphysiological creserve
B. Reduced chomeostatic cmechanisms
C. Impaired cimmunological cresponse
D. All cof cthe cabove
2. The cstrongest cevidence cregarding cnormal cphysiological caging cis cavailable cthrough:
,A. Randomized ccontrolled cclinical ctrials
B. Cross-sectionalcstudies
C. Longitudinal cstudies
D. Case ccontrolcstudies
cc c 3. c All cof cthe cfollowing cstatements care ctrue cabout claboratory
values cin colder cadultsexcept:
A. Reference cranges care cpreferable
B. Abnormal cfindings care coften c due cto cphysiological caging
C. Normal cranges cmay cnot cbe capplicable cfor colder cadults
D. Reference cvalues care cnot cnecessarily cacceptable cvalues
cc c 4. c Biochemical cindividuality cis cbest cdescribed cas:
A. Each cindividual’s cvariation cis coften cmuch cgreater cthan cthat cof ca clarger c group
B. The cunique cbiochemical cprofile cof ca cselected cpopulation
C. The ctruly c“normal” c individual—falling cwithin caverage crange
D. Each cindividual’s cvariation cis coften cmuch csmaller cthan cthat cof ca clarger cgroup
cc c 5. c Polypharmacy cis cbest cdescribed cas ctaking:
A. More cthan cnine c medications cper cday
B. More cthan cfive cmedications cper cday
, C. Even ca csingle cmedication cif c there cis c not ca cclear cindication cfor cits c use
D. When ca cdrug cis cgiven cto c treat cthe cside ceffect cof canother cdrug
cc c 6. c Pharmacokinetic cchanges cwith caging cis creflective cof:
A. What cthe cdrug cdoes cto cthe cbody
B. What cthe cbody cdoes cto cthe cdrug
C. The ceffect c at cthe csite cof caction cand cthe ctime cand cintensity cof c the c drug
D. The cside ceffects ccommonly cassociated cwith cthe cdrug
cc c 7. c All cthe cfollowing cstatements care cfalse cabout cdrug cabsorption cexcept:
A. Antacids cincrease cthe cbioavailability cof cdigitalis
B. Gastric cacidity cdecreases cwith cage
C. Anticholinergics cincrease ccolonic cmotility
D. Underlying cchronic cdisease c has clittle cimpact con cdrug cabsorption
cc c 8. c All cof cthe cfollowing cstatements care ctrue cabout cdrug cdistribution cin cthe
elderly cexcept:
A. Drugs cdistributed cin cwater chave clower cconcentration
B. Drugs cdistributed cin cfat chave cless cintense, cmore cprolonged ceffect
C. Drugs chighly cprotein cbound chave c greater cpotential cto ccause can cadverse cdrug creaction
c c c c c
c in the Care of Older Adults, 3rd Edition
c c c c c c c c
by Laurie Kennedy-Malone, Verified Chapters 1 - 23, Complete
c c c c c c c c
, Answers at the end of the Chapter
c c c c c c c
Chapter 1: Changes with Aging
c c c c
Multiple cChoice
Identify cthe c choice cthat cbest ccompletes cthe cstatement cor canswers cthe cquestion.
1. The cmajor cimpact cofcthe cphysiological cchanges cthat coccur cwith caging cis:
A. Reduced cphysiological creserve
B. Reduced chomeostatic cmechanisms
C. Impaired cimmunological cresponse
D. All cof cthe cabove
2. The cstrongest cevidence cregarding cnormal cphysiological caging cis cavailable cthrough:
,A. Randomized ccontrolled cclinical ctrials
B. Cross-sectionalcstudies
C. Longitudinal cstudies
D. Case ccontrolcstudies
cc c 3. c All cof cthe cfollowing cstatements care ctrue cabout claboratory
values cin colder cadultsexcept:
A. Reference cranges care cpreferable
B. Abnormal cfindings care coften c due cto cphysiological caging
C. Normal cranges cmay cnot cbe capplicable cfor colder cadults
D. Reference cvalues care cnot cnecessarily cacceptable cvalues
cc c 4. c Biochemical cindividuality cis cbest cdescribed cas:
A. Each cindividual’s cvariation cis coften cmuch cgreater cthan cthat cof ca clarger c group
B. The cunique cbiochemical cprofile cof ca cselected cpopulation
C. The ctruly c“normal” c individual—falling cwithin caverage crange
D. Each cindividual’s cvariation cis coften cmuch csmaller cthan cthat cof ca clarger cgroup
cc c 5. c Polypharmacy cis cbest cdescribed cas ctaking:
A. More cthan cnine c medications cper cday
B. More cthan cfive cmedications cper cday
, C. Even ca csingle cmedication cif c there cis c not ca cclear cindication cfor cits c use
D. When ca cdrug cis cgiven cto c treat cthe cside ceffect cof canother cdrug
cc c 6. c Pharmacokinetic cchanges cwith caging cis creflective cof:
A. What cthe cdrug cdoes cto cthe cbody
B. What cthe cbody cdoes cto cthe cdrug
C. The ceffect c at cthe csite cof caction cand cthe ctime cand cintensity cof c the c drug
D. The cside ceffects ccommonly cassociated cwith cthe cdrug
cc c 7. c All cthe cfollowing cstatements care cfalse cabout cdrug cabsorption cexcept:
A. Antacids cincrease cthe cbioavailability cof cdigitalis
B. Gastric cacidity cdecreases cwith cage
C. Anticholinergics cincrease ccolonic cmotility
D. Underlying cchronic cdisease c has clittle cimpact con cdrug cabsorption
cc c 8. c All cof cthe cfollowing cstatements care ctrue cabout cdrug cdistribution cin cthe
elderly cexcept:
A. Drugs cdistributed cin cwater chave clower cconcentration
B. Drugs cdistributed cin cfat chave cless cintense, cmore cprolonged ceffect
C. Drugs chighly cprotein cbound chave c greater cpotential cto ccause can cadverse cdrug creaction
